1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SAREPTA THERAPEUTICS INC
Sarepta Therapeutics Inc XNAS: SRPT
18.54 2.71 (17.12%)
15.1M
XNAS Volume

XNAS 30 Jul, 2025 10:21 AM (EDT)

USFDA Approval
Sarepta rises on Wednesday as USFDA allows it to resume shipments of its gene therapy drug Elevidys See details

Sarepta Therapeutics Inc Splits, Dividends and Corporate Actions

Check all corporate actions such as stock splits, dividends, mergers & acquisitions, and board meeting announcements for Sarepta Therapeutics Inc